Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...
STOCKHOLM, SE / ACCESS Newswire / October 14, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the ...
Biotechnology company Unlocked Labs Inc. recently graduated from the University of Wyoming’s IMPACT 307 business incubator, ...
Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...
Smithsonian Magazine on MSN
Horseshoe Crab Blood Has Long Helped Us Make Safe Medicines. Now, Alternatives That Spare the Ancient Creatures Might Be Breaking Through
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
What if a soft material could move on its own, guided not by electronics or motors, but by the kind of rudimentary chemical ...
STOCKHOLM, SE / ACCESS Newswire / October 14, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the n ...
They observe how the mobile DNA LINE-1 copies its sequence in human cells, revealing the precise mechanism of the ORF2p gene.
Aicuris has reported the success of a phase 3 trial, which has demonstrated the superiority of oral antiviral pritelivir ...
Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting ...
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation. MIAMI, FL / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback